Animal Antimicrobials-United States Market Status and Trend Report 2013-2023
Report Summary
Animal Antimicrobials-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Antimicrobials industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Animal Antimicrobials 2013-2017, and development forecast 2018-2023
Main market players of Animal Antimicrobials in United States, with company and product introduction, position in the Animal Antimicrobials market
Market status and development trend of Animal Antimicrobials by types and applications
Cost and profit status of Animal Antimicrobials, and marketing status
Market growth drivers and challenges
The report segments the United States Animal Antimicrobials market as:
United States Animal Antimicrobials Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Animal Antimicrobials Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Premixes
Oral Powders
Oral Solutions
Injections
Others
United States Animal Antimicrobials Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Food-producing Animals
Companion Animals
United States Animal Antimicrobials Market: Players Segment Analysis (Company and Product introduction, Animal Antimicrobials Sales Volume, Revenue, Price and Gross Margin):
Zoetis, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck & Co., Inc.
Bayer AG
Sanofi
Ceva Sante Animale
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Animal Antimicrobials-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Antimicrobials industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Animal Antimicrobials 2013-2017, and development forecast 2018-2023
Main market players of Animal Antimicrobials in United States, with company and product introduction, position in the Animal Antimicrobials market
Market status and development trend of Animal Antimicrobials by types and applications
Cost and profit status of Animal Antimicrobials, and marketing status
Market growth drivers and challenges
The report segments the United States Animal Antimicrobials market as:
United States Animal Antimicrobials Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Animal Antimicrobials Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Premixes
Oral Powders
Oral Solutions
Injections
Others
United States Animal Antimicrobials Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Food-producing Animals
Companion Animals
United States Animal Antimicrobials Market: Players Segment Analysis (Company and Product introduction, Animal Antimicrobials Sales Volume, Revenue, Price and Gross Margin):
Zoetis, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck & Co., Inc.
Bayer AG
Sanofi
Ceva Sante Animale
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ANIMAL ANTIMICROBIALS
1.1 Definition of Animal Antimicrobials in This Report
1.2 Commercial Types of Animal Antimicrobials
1.2.1 Premixes
1.2.2 Oral Powders
1.2.3 Oral Solutions
1.2.4 Injections
1.2.5 Others
1.3 Downstream Application of Animal Antimicrobials
1.3.1 Food-producing Animals
1.3.2 Companion Animals
1.4 Development History of Animal Antimicrobials
1.5 Market Status and Trend of Animal Antimicrobials 2013-2023
1.5.1 United States Animal Antimicrobials Market Status and Trend 2013-2023
1.5.2 Regional Animal Antimicrobials Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Antimicrobials in United States 2013-2017
2.2 Consumption Market of Animal Antimicrobials in United States by Regions
2.2.1 Consumption Volume of Animal Antimicrobials in United States by Regions
2.2.2 Revenue of Animal Antimicrobials in United States by Regions
2.3 Market Analysis of Animal Antimicrobials in United States by Regions
2.3.1 Market Analysis of Animal Antimicrobials in New England 2013-2017
2.3.2 Market Analysis of Animal Antimicrobials in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Animal Antimicrobials in The Midwest 2013-2017
2.3.4 Market Analysis of Animal Antimicrobials in The West 2013-2017
2.3.5 Market Analysis of Animal Antimicrobials in The South 2013-2017
2.3.6 Market Analysis of Animal Antimicrobials in Southwest 2013-2017
2.4 Market Development Forecast of Animal Antimicrobials in United States 2018-2023
2.4.1 Market Development Forecast of Animal Antimicrobials in United States 2018-2023
2.4.2 Market Development Forecast of Animal Antimicrobials by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Animal Antimicrobials in United States by Types
3.1.2 Revenue of Animal Antimicrobials in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Animal Antimicrobials in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Antimicrobials in United States by Downstream Industry
4.2 Demand Volume of Animal Antimicrobials by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Antimicrobials by Downstream Industry in New England
4.2.2 Demand Volume of Animal Antimicrobials by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Animal Antimicrobials by Downstream Industry in The Midwest
4.2.4 Demand Volume of Animal Antimicrobials by Downstream Industry in The West
4.2.5 Demand Volume of Animal Antimicrobials by Downstream Industry in The South
4.2.6 Demand Volume of Animal Antimicrobials by Downstream Industry in Southwest
4.3 Market Forecast of Animal Antimicrobials in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL ANTIMICROBIALS
5.1 United States Economy Situation and Trend Overview
5.2 Animal Antimicrobials Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL ANTIMICROBIALS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Animal Antimicrobials in United States by Major Players
6.2 Revenue of Animal Antimicrobials in United States by Major Players
6.3 Basic Information of Animal Antimicrobials by Major Players
6.3.1 Headquarters Location and Established Time of Animal Antimicrobials Major Players
6.3.2 Employees and Revenue Level of Animal Antimicrobials Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL ANTIMICROBIALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis, Inc.
7.1.1 Company profile
7.1.2 Representative Animal Antimicrobials Product
7.1.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Zoetis, Inc.
7.2 Boehringer Ingelheim GmbH
7.2.1 Company profile
7.2.2 Representative Animal Antimicrobials Product
7.2.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH
7.3 Eli Lilly and Company
7.3.1 Company profile
7.3.2 Representative Animal Antimicrobials Product
7.3.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.4 Merck & Co., Inc.
7.4.1 Company profile
7.4.2 Representative Animal Antimicrobials Product
7.4.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
7.5 Bayer AG
7.5.1 Company profile
7.5.2 Representative Animal Antimicrobials Product
7.5.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Bayer AG
7.6 Sanofi
7.6.1 Company profile
7.6.2 Representative Animal Antimicrobials Product
7.6.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Sanofi
7.7 Ceva Sante Animale
7.7.1 Company profile
7.7.2 Representative Animal Antimicrobials Product
7.7.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Animal Antimicrobials Product
7.8.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol S.A.
7.9.1 Company profile
7.9.2 Representative Animal Antimicrobials Product
7.9.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Vetoquinol S.A.
7.10 Dechra Pharmaceuticals PLC
7.10.1 Company profile
7.10.2 Representative Animal Antimicrobials Product
7.10.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Dechra Pharmaceuticals PLC
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL ANTIMICROBIALS
8.1 Industry Chain of Animal Antimicrobials
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL ANTIMICROBIALS
9.1 Cost Structure Analysis of Animal Antimicrobials
9.2 Raw Materials Cost Analysis of Animal Antimicrobials
9.3 Labor Cost Analysis of Animal Antimicrobials
9.4 Manufacturing Expenses Analysis of Animal Antimicrobials
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL ANTIMICROBIALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Animal Antimicrobials in This Report
1.2 Commercial Types of Animal Antimicrobials
1.2.1 Premixes
1.2.2 Oral Powders
1.2.3 Oral Solutions
1.2.4 Injections
1.2.5 Others
1.3 Downstream Application of Animal Antimicrobials
1.3.1 Food-producing Animals
1.3.2 Companion Animals
1.4 Development History of Animal Antimicrobials
1.5 Market Status and Trend of Animal Antimicrobials 2013-2023
1.5.1 United States Animal Antimicrobials Market Status and Trend 2013-2023
1.5.2 Regional Animal Antimicrobials Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Antimicrobials in United States 2013-2017
2.2 Consumption Market of Animal Antimicrobials in United States by Regions
2.2.1 Consumption Volume of Animal Antimicrobials in United States by Regions
2.2.2 Revenue of Animal Antimicrobials in United States by Regions
2.3 Market Analysis of Animal Antimicrobials in United States by Regions
2.3.1 Market Analysis of Animal Antimicrobials in New England 2013-2017
2.3.2 Market Analysis of Animal Antimicrobials in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Animal Antimicrobials in The Midwest 2013-2017
2.3.4 Market Analysis of Animal Antimicrobials in The West 2013-2017
2.3.5 Market Analysis of Animal Antimicrobials in The South 2013-2017
2.3.6 Market Analysis of Animal Antimicrobials in Southwest 2013-2017
2.4 Market Development Forecast of Animal Antimicrobials in United States 2018-2023
2.4.1 Market Development Forecast of Animal Antimicrobials in United States 2018-2023
2.4.2 Market Development Forecast of Animal Antimicrobials by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Animal Antimicrobials in United States by Types
3.1.2 Revenue of Animal Antimicrobials in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Animal Antimicrobials in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Antimicrobials in United States by Downstream Industry
4.2 Demand Volume of Animal Antimicrobials by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Antimicrobials by Downstream Industry in New England
4.2.2 Demand Volume of Animal Antimicrobials by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Animal Antimicrobials by Downstream Industry in The Midwest
4.2.4 Demand Volume of Animal Antimicrobials by Downstream Industry in The West
4.2.5 Demand Volume of Animal Antimicrobials by Downstream Industry in The South
4.2.6 Demand Volume of Animal Antimicrobials by Downstream Industry in Southwest
4.3 Market Forecast of Animal Antimicrobials in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL ANTIMICROBIALS
5.1 United States Economy Situation and Trend Overview
5.2 Animal Antimicrobials Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL ANTIMICROBIALS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Animal Antimicrobials in United States by Major Players
6.2 Revenue of Animal Antimicrobials in United States by Major Players
6.3 Basic Information of Animal Antimicrobials by Major Players
6.3.1 Headquarters Location and Established Time of Animal Antimicrobials Major Players
6.3.2 Employees and Revenue Level of Animal Antimicrobials Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL ANTIMICROBIALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis, Inc.
7.1.1 Company profile
7.1.2 Representative Animal Antimicrobials Product
7.1.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Zoetis, Inc.
7.2 Boehringer Ingelheim GmbH
7.2.1 Company profile
7.2.2 Representative Animal Antimicrobials Product
7.2.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH
7.3 Eli Lilly and Company
7.3.1 Company profile
7.3.2 Representative Animal Antimicrobials Product
7.3.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.4 Merck & Co., Inc.
7.4.1 Company profile
7.4.2 Representative Animal Antimicrobials Product
7.4.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
7.5 Bayer AG
7.5.1 Company profile
7.5.2 Representative Animal Antimicrobials Product
7.5.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Bayer AG
7.6 Sanofi
7.6.1 Company profile
7.6.2 Representative Animal Antimicrobials Product
7.6.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Sanofi
7.7 Ceva Sante Animale
7.7.1 Company profile
7.7.2 Representative Animal Antimicrobials Product
7.7.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Animal Antimicrobials Product
7.8.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol S.A.
7.9.1 Company profile
7.9.2 Representative Animal Antimicrobials Product
7.9.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Vetoquinol S.A.
7.10 Dechra Pharmaceuticals PLC
7.10.1 Company profile
7.10.2 Representative Animal Antimicrobials Product
7.10.3 Animal Antimicrobials Sales, Revenue, Price and Gross Margin of Dechra Pharmaceuticals PLC
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL ANTIMICROBIALS
8.1 Industry Chain of Animal Antimicrobials
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL ANTIMICROBIALS
9.1 Cost Structure Analysis of Animal Antimicrobials
9.2 Raw Materials Cost Analysis of Animal Antimicrobials
9.3 Labor Cost Analysis of Animal Antimicrobials
9.4 Manufacturing Expenses Analysis of Animal Antimicrobials
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL ANTIMICROBIALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
